These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 36205102)

  • 1. α-Adrenergic blockade prevented environmental temperature reduction-induced transient portal pressure surge in cirrhotic and portal hypertensive rats.
    Huang HC; Chang CC; Pun CK; Tsai MH; Chuang CL; Hsu SJ; Huang YH; Hou MC; Lee FY
    Clin Sci (Lond); 2022 Oct; 136(20):1449-1466. PubMed ID: 36205102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacologic prevention of variceal bleeding and rebleeding.
    Baiges A; Hernández-Gea V; Bosch J
    Hepatol Int; 2018 Feb; 12(Suppl 1):68-80. PubMed ID: 29210030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nebivolol treatment increases splanchnic blood flow and portal pressure in cirrhotic rats via modulation of nitric oxide signalling.
    Reiberger T; Payer BA; Schwabl P; Hayden H; Horvatits T; Jäger B; Hummel T; Mitterhauser M; Trauner M; Fuhrmann V; Angermayr B; Peck-Radosavljevic M;
    Liver Int; 2013 Apr; 33(4):561-8. PubMed ID: 23331709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined administration of propranolol + AG490 offers better effects on portal hypertensive rats with cirrhosis.
    Wang D; Wang Q; Yin J; Dong R; Wang Q; Du X; Lu J
    J Gastroenterol Hepatol; 2016 May; 31(5):1037-44. PubMed ID: 26487394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic and splanchnic hemodynamics following hemorrhage and volume restitution with Haemaccel in portal hypertensive rats: the effect of propranolol.
    Hilzenrat N; Arish A; Yaari A; Sikuler E
    J Gastroenterol Hepatol; 2001 Jul; 16(7):796-800. PubMed ID: 11446889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amelioration of portal hypertension and the hyperdynamic circulatory syndrome in cirrhotic rats by neuropeptide Y via pronounced splanchnic vasoaction.
    Moleda L; Trebicka J; Dietrich P; Gäbele E; Hellerbrand C; Straub RH; Sauerbruch T; Schoelmerich J; Wiest R
    Gut; 2011 Aug; 60(8):1122-32. PubMed ID: 21317421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zolmitriptan: a novel portal hypotensive agent which synergizes with propranolol in lowering portal pressure.
    Reboredo M; Chang HC; Barbero R; Rodríguez-Ortigosa CM; Pérez-Vizcaíno F; Morán A; García M; Banales JM; Carreño N; Alegre F; Herrero I; Quiroga J; Prieto J; Sangro B
    PLoS One; 2013; 8(1):e52683. PubMed ID: 23341903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The beneficial effects of curcumin in cirrhotic rats with portal hypertension.
    Hsu SJ; Lee JY; Lin TY; Hsieh YH; Huang HC; Lee FY; Lin HC; Hou MC; Lee SD
    Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 29162665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Portal hypertension and blood viscosity.
    Sikuler E
    J Clin Gastroenterol; 2007; 41 Suppl 3():S262-5. PubMed ID: 17975475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbiota transplants from feces or gut content attenuated portal hypertension and portosystemic collaterals in cirrhotic rats.
    Huang HC; Tsai MH; Chang CC; Pun CK; Huang YH; Hou MC; Lee FY; Hsu SJ
    Clin Sci (Lond); 2021 Dec; 135(24):2709-2728. PubMed ID: 34870313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of terlipressin on hemodynamics and oxygen content in conscious portal vein stenosed and cirrhotic rats receiving propranolol.
    Lebrec D; Moreau R; Cailmail S; Sogni P; Oberti F; Hadengue A
    J Hepatol; 1993 Jan; 17(1):102-7. PubMed ID: 8445208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual angiotensin receptor and neprilysin inhibitor reduced portal pressure through peripheral vasodilatation and decreasing systemic arterial pressure in cirrhotic rats.
    Pun CK; Chang CC; Chuang CL; Huang HC; Hsu SJ; Huang YH; Hou MC; Lee FY
    J Chin Med Assoc; 2023 Sep; 86(9):786-794. PubMed ID: 37462441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemodynamic effects of nipradilol, a new beta-adrenergic antagonist combined with a nitroxy base, in rats with intra- or extra-hepatic portal hypertension.
    Ohsuga M; Cailmail S; Lebrec D
    J Hepatol; 1993 Feb; 17(2):236-40. PubMed ID: 8095275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cirrhotic portal hypertension: current and future medical therapy for primary and secondary prevention of variceal bleeding.
    Laleman W; Nevens F
    Minerva Med; 2006 Aug; 97(4):325-45. PubMed ID: 17008837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of norepinephrine and acetylcholine on portal-systemic collaterals of common bile duct-ligated cirrhotic rat.
    Chan CC; Chang CC; Huang HC; Wang SS; Lee FY; Chang FY; Lin HC; Tai CC; Lee SD
    J Gastroenterol Hepatol; 2005 Dec; 20(12):1867-72. PubMed ID: 16336446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complications of cirrhosis. I. Portal hypertension.
    Bosch J; García-Pagán JC
    J Hepatol; 2000; 32(1 Suppl):141-56. PubMed ID: 10728801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood in the gastric lumen increases splanchnic blood flow and portal pressure in portal-hypertensive rats.
    Chen L; Groszmann RJ
    Gastroenterology; 1996 Oct; 111(4):1103-10. PubMed ID: 8831606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid change of liver stiffness after variceal ligation and TIPS implantation.
    Piecha F; Paech D; Sollors J; Seitz HK; Rössle M; Rausch V; Mueller S
    Am J Physiol Gastrointest Liver Physiol; 2018 Feb; 314(2):G179-G187. PubMed ID: 29051188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Propranolol modulates the collateral vascular responsiveness to vasopressin via a G(α)-mediated pathway in portal hypertensive rats.
    Lee JY; Huo TI; Huang HC; Lee FY; Lin HC; Chuang CL; Chang CC; Wang SS; Lee SD
    Clin Sci (Lond); 2011 Dec; 121(12):545-54. PubMed ID: 21736560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pioglitazone decreases portosystemic shunting by modulating inflammation and angiogenesis in cirrhotic and non-cirrhotic portal hypertensive rats.
    Schwabl P; Payer BA; Grahovac J; Klein S; Horvatits T; Mitterhauser M; Stift J; Boucher Y; Trebicka J; Trauner M; Angermayr B; Fuhrmann V; Reiberger T; Peck-Radosavljevic M
    J Hepatol; 2014 Jun; 60(6):1135-42. PubMed ID: 24530596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.